These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 2431109)
21. Dopamine receptors and the dopamine hypothesis of schizophrenia. Seeman P Synapse; 1987; 1(2):133-52. PubMed ID: 2905529 [TBL] [Abstract][Full Text] [Related]
22. Dopamine receptor changes in response to prolonged treatment with L-dopa. Groppetti A; Flauto C; Parati E; Vescovi A; Rusconi L; Parenti M J Neural Transm Suppl; 1986; 22():33-45. PubMed ID: 2946813 [TBL] [Abstract][Full Text] [Related]
23. RDS-127 (2-di-n-propylamino-4,7-dimethoxyindane): central effects of a new dopamine receptor agonist. Arnerić SP; Long JP; Williams M; Goodale DB; Mott J; Lakoski JM; Gebhart GF J Pharmacol Exp Ther; 1983 Jan; 224(1):161-70. PubMed ID: 6401334 [TBL] [Abstract][Full Text] [Related]
24. Effects of chronic SCH23390 treatment on the biochemical and behavioral properties of D1 and D2 dopamine receptors: potentiated behavioral responses to a D2 dopamine agonist after selective D1 dopamine receptor upregulation. Hess EJ; Albers LJ; Le H; Creese I J Pharmacol Exp Ther; 1986 Sep; 238(3):846-54. PubMed ID: 3018223 [TBL] [Abstract][Full Text] [Related]
25. Dopamine receptor system involving adenylate cyclase in canine caudate nucleus. Maeno H; Sano K; Nishikori K; Noshiro O; Sato A; Yoneda T; Usuda S; Iwanami S Adv Biochem Psychopharmacol; 1983; 36():175-83. PubMed ID: 6344564 [TBL] [Abstract][Full Text] [Related]
31. D2S, D2L, D3, and D4 dopamine receptors couple to a voltage-dependent potassium current in N18TG2 x mesencephalon hybrid cell (MES-23.5) via distinct G proteins. Liu LX; Burgess LH; Gonzalez AM; Sibley DR; Chiodo LA Synapse; 1999 Feb; 31(2):108-18. PubMed ID: 10024007 [TBL] [Abstract][Full Text] [Related]
32. K+ channel and adenylate cyclase involvement in regulation of Ca2+-evoked release of [3H]dopamine from synaptosomes. Bowyer JF; Weiner N J Pharmacol Exp Ther; 1989 Feb; 248(2):514-20. PubMed ID: 2465405 [TBL] [Abstract][Full Text] [Related]
33. Amygdaloid D1 receptors are not linked to stimulation of adenylate cyclase. Leonard SK; Anderson CM; Lachowicz JE; Schulz DW; Kilts CD; Mailman RB Synapse; 2003 Dec; 50(4):320-33. PubMed ID: 14556237 [TBL] [Abstract][Full Text] [Related]
34. Diversity of dopamine receptors: new molecular and pharmacological developments. Hartman DS; Lanau F Pol J Pharmacol; 1997 Aug; 49(4):191-9. PubMed ID: 9437762 [TBL] [Abstract][Full Text] [Related]
35. [Dopaminergic modifications caused by neuroleptics. Functional and therapeutic hypotheses on tardive dyskinesias]. Tassin JP Encephale; 1988 Sep; 14 Spec No():157-62. PubMed ID: 2905643 [TBL] [Abstract][Full Text] [Related]
36. Characterization of a chimeric human dopamine D3/D2 receptor functionally coupled to adenylyl cyclase in Chinese hamster ovary cells. Van Leeuwen DH; Eisenstein J; O'Malley K; MacKenzie RG Mol Pharmacol; 1995 Aug; 48(2):344-51. PubMed ID: 7651368 [TBL] [Abstract][Full Text] [Related]
37. [Dopamine effect on ionic conduction and adenyl cyclase activity in the central nervous system of the pond snail]. Prudnikov IM; Osipenko ON; Kastrikina TF; Tsyvkin VN Neirofiziologiia; 1992; 24(4):437-51. PubMed ID: 1436209 [TBL] [Abstract][Full Text] [Related]
40. The history and pharmacology of dopamine agonists. Lataste X Can J Neurol Sci; 1984 Feb; 11(1 Suppl):118-23. PubMed ID: 6713309 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]